AWM Investment Company Inc. Has $19.24 Million Holdings in ASP Isotopes Inc. (NASDAQ:ASPI)

AWM Investment Company Inc. grew its stake in ASP Isotopes Inc. (NASDAQ:ASPI) by 16.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,246,186 shares of the company’s stock after purchasing an additional 586,600 shares during the period. ASP Isotopes comprises approximately 2.3% of AWM Investment Company Inc.’s investment portfolio, making the stock its 10th largest position. AWM Investment Company Inc. owned 5.95% of ASP Isotopes worth $19,235,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Hanson & Doremus Investment Management bought a new position in ASP Isotopes in the 4th quarter valued at approximately $27,000. BNP Paribas Financial Markets bought a new stake in ASP Isotopes during the 4th quarter worth approximately $34,000. Avantax Advisory Services Inc. acquired a new position in ASP Isotopes in the 4th quarter valued at approximately $45,000. Russell Investments Group Ltd. lifted its holdings in shares of ASP Isotopes by 56.3% during the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company’s stock worth $46,000 after purchasing an additional 3,682 shares during the period. Finally, SVB Wealth LLC acquired a new position in shares of ASP Isotopes during the fourth quarter worth $49,000. 16.80% of the stock is owned by institutional investors.

Insider Buying and Selling at ASP Isotopes

In other ASP Isotopes news, CEO Paul Elliot Mann sold 316,666 shares of the firm’s stock in a transaction that occurred on Thursday, April 17th. The shares were sold at an average price of $5.62, for a total transaction of $1,779,662.92. Following the completion of the transaction, the chief executive officer now owns 7,315,454 shares in the company, valued at approximately $41,112,851.48. This trade represents a 4.15% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Robert Ainscow sold 66,668 shares of the business’s stock in a transaction that occurred on Thursday, April 17th. The stock was sold at an average price of $5.62, for a total transaction of $374,674.16. Following the completion of the transaction, the chief operating officer now owns 1,419,992 shares in the company, valued at $7,980,355.04. This trade represents a 4.48% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 766,667 shares of company stock worth $4,358,502. Insiders own 21.40% of the company’s stock.

ASP Isotopes Stock Performance

NASDAQ ASPI opened at $7.00 on Wednesday. The company has a market capitalization of $525.43 million, a price-to-earnings ratio of -11.48 and a beta of 3.40. ASP Isotopes Inc. has a twelve month low of $1.86 and a twelve month high of $9.33. The stock has a fifty day simple moving average of $5.34 and a 200 day simple moving average of $5.44. The company has a quick ratio of 7.54, a current ratio of 7.55 and a debt-to-equity ratio of 0.80.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.